Phase 2

ascletis-highlights-promising-glp-1-dosing-mineralys-phase-2-falls-short

Ascletis Highlights Promising GLP-1 Dosing; Mineralys Phase 2 Falls Short

Editorial 10 March, 2026

Ascletis Pharmaceuticals has reported promising data regarding its quarterly dosing regimen for GLP-1, a...

ruvi-ai-set-to-explode-after-coinmarketcap-listing-analysts-say

Ruvi AI Set to Explode After CoinMarketCap Listing, Analysts Say

Editorial 2 August, 2025

Investors are turning their attention to Ruvi AI (RUVI) following its recent listing on...